BioMerieux 新闻与活动
在场
BioMerieux 的所有者是 Institut Merieux.
Institut Merieux 在 3 个国家有直接业务。
Institut Merieux 拥有 7家子公司，其中包括 Advanced BioScience Laboratories、BioMerieux 和 BioMerieux Americas。
他们在：
高管
查看带有其 37 名主要高管的组织结构图
BioMerieux 搜索最多的简介
- Pierre Boulud, Chief Executive Officer
- Alexandre Merieux, Chairman of the Board
- Marie-Paule Kieny, Independent Director
创建提醒
跟踪 BioMerieux 的高管变动
药店
Institut Merieux 拥有 1,834 家竞争者，其中包括 Pfizer (美国(美洲))、Eli Lilly (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Clario 已收购 NRx Pharmaceuticals (公布2025三月18号).
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
药店 行业的其他推荐联系人
消息
BioMerieux 的最新新闻稿
- bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
- Press Releases
- Press Releases
- bioMérieux – 2024 Financial Results
- bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid
- bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes
- Communiqués de presse
- bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip
- bioMérieux to present at the 43rd Annual J.P. Morgan HealthCare Conference
- BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance
- View more press releases Close
